Supplemental Table.
DENV | DENV/ZIKV | ZIKV | |||
---|---|---|---|---|---|
Demographic and laboratory characteristics | Without WS (n=46) | With WS/Severe (n=8) | Without WS (n=12) | With WS/Severe (n=3) | (n=15) |
Gender F:M | 22:24 | 6:2 | 5:7 | 1:2 | 12:3 |
Age Median (LCL-UCL) | 33 (31.1-39.8) | 46.5 (31.15-39.8) | 25.5 (23.4-44.1) | 21 (12-71) | 40 (32.6-45.26) |
a Days of disease ΩMedian (LCL-UCL) | 3.5 (2.5-4.4) | 4.5 (0.7-11) | 25.5 (23.4-44.1) | 21 (12-71) | 40 (32.6-45.26) |
DENV-1 (n/total) | 33/38 | 5/6 | 12/13 | 3/3 | 0 |
DENV-4 (n/total) | 4/38 | 1/6 | 1/13 | 0/3 | 0 |
Hospitalization (%) | 0 | 1/6 | 0 | 0/3 | 0 |
AST (IU/L)(n=total) | 33 (36.6-78) (n=24) | 43 (18.9-69)(n=4) | 23 (24-147) (n=7) | 22.5 (16-28)(n=2) | 27.5 (21.4-32.5) (n=8) |
ALT (IU/L)(n=total) | 39.7 (37-46.4)(n=41) | 62.5 (113-346)(n=4) | 28 (5.8-93) (n=11) | 16 (10-22.5)(n=3) | 23 (17-28.1)(n=13) |
Total proteins (g/dL) | 7.3 (7.1-7.4)(n=40) | 7.0 (6.4-7.7)(n=6) | 7.3 (7.1-7.4)(n=14) | 7.0 (6.4-7.7)(n=3) | 7.0 (6.4-7.7)(n=15) |
Albumin (g/dL) | 4.05 (4.07-4.2(n=40) | 4.2 (3.4-4.5)(n=6) | 4.3 (4.1-4.4)(n=14) | 4.1 (2.4-6.0)(n=3) | 4.2 (4.05-4.4)(n=13) |
Hematocrit (%) | 41 (40.7-42.5)(n=46) | 39.5 (33.9-43)(n=8) | 43 (39-44.6)(n=14) | 39 (26-53.8)(n=3) | 41 (39.4-44.1)(n=15) |
Platelets 103 /mm3 counts | 198.5 (168-206.6) (n=46) | 101 (39.4-172.1) b***(n=8) | 188 (147-224) c*(n=12) | 193 (40-392)(n=3) | 197 (155.5-265.3) c*(n=15) |
Bleeding (%) | 0 | 6 (75%)d | 1 (7.14%)b | 2 (66%) | 0 |